Text
Plant compounds and gut microbiota activity influence how cancer drugs work and should be considered in treatment.
Tracking the oral microbiota can help identify ECC risk early and inform prevention strategies in children, even before visible signs of decay.
AceCel is a promising way to help manage obesity by targeting gut bacteria and metabolism together.
The science behind gut-brain communication and the role of intestinal integrity.
What if in 2045 you could pay rent with microbes? Discover a future where microbial credits become the new currency.
Nanoparticle-based approaches are a promising strategy for treating colorectal cancer.
Women with lower DI-GM scores showed a higher risk of infertility, highlighting the potential importance of gut microbiota diversity as a factor in female reproductive health.
Xervyteg® marks a major advance in microbiome therapeutics, with potential to become the first approved microbiota therapy in Europe.
Fungal metabolites such as FF-C1 may offer a new therapeutic approach for treating MAFLD and related conditions.
Certain barriers on the skin prevent easy colonization of new strains and specific life stages, such as adolescence, may be crucial for successful probiotic interventions.
